Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/10/2026

Maximum Dolerable and Recommended Dosing of Itraconazole

Standard Dosing and Formulation Guidance

  • The European Respiratory Society recommends that conventional itraconazole capsules may be administered up to 600 mg per day in divided doses for adults. 1
  • For conventional capsules, the usual therapeutic range is 200–400 mg per day given in divided doses, administered with meals to improve absorption. [1][2]
  • Super‑bioavailable itraconazole capsules have a maximum dose of 390 mg per day; the standard regimen is 260 mg per day divided into two doses, and they should be taken on an empty stomach. 1

Pediatric Dosing

  • In children, the maximum dose is capped at 400 mg per day, irrespective of weight‑based calculations. [2][3]4
  • Weight‑based dosing of 10 mg/kg per day may be used for severe infections but must not exceed 400 mg per day. [2][3]

Clinical Indications for High‑Dose Itraconazole (Up to 600 mg/day)

  • For central nervous system (CNS) fungal infections, a regimen of 200 mg three times daily (total 600 mg/day) can be employed as step‑down therapy after amphotericin B treatment. [3][4]
  • Most fungal infections are effectively managed with 200–400 mg per day; higher doses have not shown additional benefit in blastomycosis. [1][2]3
  • In allergic bronchopulmonary aspergillosis, the standard dose is 400 mg per day, with 600 mg per day defined as the upper limit. 1

Therapeutic Drug Monitoring (TDM)

  • Serum itraconazole concentrations should be measured after at least 2 weeks of therapy to guide dosing adjustments. 5
  • The target therapeutic trough level is ≥ 1 µg/mL; levels > 10 µg/mL may signal an increased risk of toxicity. [5][6]

Safety, Monitoring, and Contraindications

  • Heart failure is an absolute contraindication to high‑dose itraconazole because of its negative inotropic effects. 7
  • Active liver disease or existing hepatotoxicity precludes the use of high‑dose itraconazole. 7
  • Pregnancy: itraconazole should be avoided; amphotericin B is the preferred agent. 4
  • The oral solution of itraconazole has superior bioavailability compared with capsules and should not be interchanged without adjusting the dose. 8

Practical Dosing Algorithm (Summary)

  • Begin with standard dosing (200–400 mg/day) and assess clinical response.
  • Perform TDM after 2 weeks; if trough levels remain < 1 µg/mL despite optimal dosing, consider escalation to 600 mg/day only in severe, life‑threatening infections and under close monitoring for electrolyte disturbances, blood pressure changes, and adrenal function.

All facts are derived from cited guideline and peer‑reviewed sources; strength of evidence is as reported in the original references.

Itraconazole Therapeutic Drug Monitoring and Toxicity Thresholds

Toxic Serum Concentrations

Therapeutic Target Levels

Standard Dosing Recommendations

Monitoring Algorithm for High‑Dose Therapy

Hepatotoxicity Surveillance

Importance of Therapeutic Drug Monitoring (TDM)

Drug‑Drug Interaction Considerations

Pharmacokinetic Timing

Evidence on Dose Efficacy